Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevalence of the OCS Use Among Severe Asthma Patients in Egypt: A Nation-wide, Cross-Sectional, Multicenter Study

NCT06283290 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT06283290
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06283290 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevalence of the OCS Use Among Severe Asthma Patients in Egypt: A Nation-wide, Cross-Sectional, Multicenter Study
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
March 12, 2024
Completion date
November 28, 2024
Enrollment
201 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

severe asthma